• Dr. Morten Bøttcher Head of the Cardiac Imaging center

    Morten Bøttcher is head of the Cardiac Imaging center at the Hospital Unit West in Denmark and associate professor at Aarhus University. He is also a member of the board of representatives for the west of Denmark Heart database and has worked as secretary of the Danish society of Cardiology and secretary of the European working group on nuclear cardiology and CT. Dr. Bøttcher is the principal investigator of the DAN-NICAD trial and has a long-term interest and research activity in non-invasive and invasive diagnosis of ischemic heart disease.

  • Prof. Dr. John Cleland Prof. Dr. John Cleland

    Professor John Cleland is a cardiology consultant at the Royal Brompton Hospital and a professor of cardiology at the Imperial College London as well as Director of the Robertson centre for Biostatistics and Clinical Trials and he is also Honorary Consultant Cardiologist for the Greater Glasgow & Clyde Health Board.

  • Peter Clemmensen MD, DMSc, FESC, FSCAI

    The landscape of dual antiplatelet therapy (DAPT) is increasing in complexity with shorter duration in selected patients particularly in those with an indication for concomitant anticoagulation and still others might benefit from DAPT beyond 12 months. This lecture will address these issues and the potential for individual decision making.

  • Prof. Dr. David Erlinge Prof. Dr. David Erlinge, Sweden

    Prof. Dr. Erlinge graduated in medicine from the University of Lund, in 1990, where he also earned his PhD. He has been a visiting research fellow at Cornell University Medical College in New York. In 2006 he received the Lars Werkö distinguished research fellowship and was appointed Professor in Cardiology at Lund University in 2008. He is the Head of the Cardiology Department at the Skåne University Hospital in Lund.